In line with these findings is the study from Vriezze and colleagues [28], in which microbiota transfer from lean donors to individuals with obesity and MS led to an increase in the abundance of butyrate-producing microbes and to an increase in insulin sensitivity six weeks after the procedure. This evidence concerns the gene INS and myeloid sarcoma.